Chunna Yu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Phase 2 Trial of PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma.
Journal: CNS neuroscience & therapeutics
Published: August 06, 2025
OH2 oncolytic virus: A novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses.
Journal: Cancer letters
Published: October 28, 2023
PHF6 promotes the progression of endometrial carcinoma by increasing cancer cells growth and decreasing T-cell infiltration.
Journal: Journal of cellular and molecular medicine
Published: May 23, 2022
A Novel Classification of Glioma Subgroup, Which Is Highly Correlated With the Clinical Characteristics and Tumor Tissue Characteristics, Based on the Expression Levels of Gβ and Gγ Genes.
Journal: Frontiers in oncology
Published: March 25, 2021
Characterization of the Vaginal Microbiome in Women with Infertility and Its Potential Correlation with Hormone Stimulation during In Vitro Fertilization Surgery.
Journal: mSystems
Published: July 16, 2020
Aberrant expression of CD13 and stem cell markers in CD133-induced liver cancer in mice.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: October 25, 2019
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer.
Journal: Molecular therapy. Nucleic acids
Published: March 19, 2019
Cycloartenol exerts anti-proliferative effects on Glioma U87 cells via induction of cell cycle arrest and p38 MAPK-mediated apoptosis.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: January 06, 2019
microRNA-494 is a potential prognostic marker and inhibits cellular proliferation, migration and invasion by targeting SIRT1 in epithelial ovarian cancer.
Journal: Oncology letters
Published: November 25, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026